Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/17/2020 09/18/2020 09/21/2020 09/22/2020 09/23/2020 Date
248.08(c) 247.72(c) 243.19(c) 247.5(c) 247.03 Last
2 801 126 6 042 471 2 745 529 2 172 592 558 978 Volume
+0.13% -0.15% -1.83% +1.77% -0.19% Change
More quotes
Financials (USD)
Sales 2020 25 395 M - -
Net income 2020 6 888 M - -
Net Debt 2020 19 337 M - -
P/E ratio 2020 21,3x
Yield 2020 2,60%
Sales 2021 26 542 M - -
Net income 2021 8 088 M - -
Net Debt 2021 18 261 M - -
P/E ratio 2021 18,2x
Yield 2021 2,78%
Capitalization 142 B 142 B -
EV / Sales 2020 6,37x
EV / Sales 2021 6,05x
Nbr of Employees 23 400
Free-Float 99,8%
More Financials
Company
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc. The United States account for 74.5% of net sales; - other (5%): primarily royalties. 
Sector
Pharmaceuticals
Calendar
09/21 | 08:25amPresentation
More about the company
Notations Surperformance© of Amgen Inc.
Trading Rating : Investor Rating :
More Ratings
All news about AMGEN INC.
09/21AMGEN : AMG 160 at ESMO 2020 Presentation
PU
09/20AMGEN : Sotorasib at ESMO 2020
PU
09/20AMGEN : Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Publ..
PR
09/20MIRATI THERAPEUTICS : Amgen drug shrinks tumors in lung cancer patients with KRA..
RE
09/20Amgen says sotorasib shrank tumors in 32% of advanced lung cancer patients in..
RE
09/20Amgen says sotorasib study demonstrates progression-free survival of 6.3 mont..
RE
09/18AMGEN : Form 8937
PU
09/18AMGEN : For People With Lung Cancer, Expanded Biomarker Testing Is Key to Advanc..
PU
09/18ELI LILLY AND : Lilly and Amgen Announce Manufacturing Collaboration for COVID-1..
AQ
09/17ELI LILLY AND : Lilly, Amgen to Collaborate on Making Lilly's Potential Covid-19..
DJ
09/17AMGEN : Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibo..
PR
09/16AMGEN : To Webcast Investor Calls At ESMO 2020
PR
09/16AMGEN : To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 202..
PR
09/16AMGEN : and MBC BioLabs Announce Winners of the Amgen Golden Ticket
AQ
09/15AMGEN : to Present at the 2020 Bank of America Virtual Global Healthcare Confere..
AQ
More news
News in other languages on AMGEN INC.
09/17Wall Street : en repli après de piètres statistiques
09/17AMGEN : collaboration avec Eli Lilly dans la Covid-19
09/17Wall Street : vers une ouverture déprimée après des données
09/17ELI LILLY : collaboration avec Amgen dans la Covid-19
09/04Vifor-Partner Akebia stellt trotz Studien-Fehlschlag Vadadustat-Zulassungsant..
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 260,65 $
Last Close Price 243,19 $
Spread / Highest target 26,6%
Spread / Average Target 7,18%
Spread / Lowest Target -23,9%
EPS Revisions
Managers
NameTitle
Robert A. Bradway Chairman, President & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
Peter H. Griffith Chief Financial Officer
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN INC.0.88%142 435
JOHNSON & JOHNSON-0.53%382 023
ROCHE HOLDING AG7.64%314 692
MERCK & CO., INC.-8.60%210 256
PFIZER, INC.-6.51%200 159
NOVARTIS AG-11.23%196 086